Published in Arch Surg on May 01, 1974
Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion. J Clin Invest (1993) 1.14
Effect of bombesin and related peptides on the release and action of intestinal hormones on pancreatic secretion. J Physiol (1976) 0.89
Influence of the vagus nerve on release and action of secretin in dog. J Physiol (1979) 0.87
The response of the pancreas of the anaesthetized cat to secretin before, during and after reversible vagal blockade. J Physiol (1983) 0.85
Experimental evidence for a vagally mediated and cholecystokinin-independent enteropancreatic reflex. Ann Surg (1985) 0.81
Cholinergic component in the human pancreatic secretory response to intraintestinal oleate. Gut (1983) 0.77
Plasma cholecystokinin response to a liquid fat meal in vagotomized patients. Ann Surg (1984) 0.77
Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature (1997) 4.82
Inhibition of acid secretion in dog by metiamide, a histamine antagonist acting on H2 receptors. Gastroenterology (1974) 2.87
Behavioral changes in Huntington Disease. Neuropsychiatry Neuropsychol Behav Neurol (2001) 2.52
Domain-specific recruitment of amide amino acids for protein synthesis. Nature (2000) 2.21
ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society. Eur Respir J (2002) 2.12
Effect of secretin on circulating gastrin. Ann Surg (1972) 2.03
One polypeptide with two aminoacyl-tRNA synthetase activities. Science (2000) 1.94
Endobronchial ultrasound-guided transbronchial lung biopsy in fluoroscopically invisible solitary pulmonary nodules: a prospective trial. Chest (2006) 1.91
Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats. J Physiol (1982) 1.80
Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin. Gastroenterology (1976) 1.74
Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate. Digestion (1987) 1.69
Knowledge of famous faces and names in semantic dementia. Brain (2004) 1.68
Aspirin does not increase bleeding complications after transbronchial biopsy. Chest (2002) 1.66
Autofluorescence bronchoscopy--a comparison of two systems (LIFE and D-Light). Respiration (2003) 1.62
Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol (2011) 1.62
Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis (2001) 1.59
Glutamine is essential for epidermal growth factor-stimulated intestinal cell proliferation. Surgery (1993) 1.57
Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology (1991) 1.57
The adaptor hypothesis revisited. Trends Biochem Sci (2000) 1.56
Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J Physiol Pharmacol (2002) 1.55
Natural history and experience with diagnosis and treatment of the Zollinger-Ellison syndrome. Surg Gynecol Obstet (1975) 1.53
Dynamic characteristics of gastrin release. Am J Surg (1972) 1.53
Gastric cytoprotection by epidermal growth factor. Role of endogenous prostaglandins and DNA synthesis. Gastroenterology (1981) 1.52
Proof of a pyloro-oxyntic reflex for stimulation of acid secretion. Gastroenterology (1974) 1.51
Technique and results of transanal endoscopic microsurgery in early rectal cancer. Am J Surg (1992) 1.49
Effect of glucagon on meal-induced gastric secretion in man. Gastroenterology (1975) 1.49
Influence of hypercalcemia on gastric secretion and serum gastrin concentrations in man. Ann Surg (1970) 1.45
Influence of endogenous prostaglandins on secretin-mediated inhibition of gastric acid secretion in dogs. Gastroenterology (1988) 1.42
Endobronchial ultrasound-guided transbronchial lung biopsy in solitary pulmonary nodules and peripheral lesions. Eur Respir J (2002) 1.41
Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology (1981) 1.40
Human monoclonal antibody against colon cancer. Cancer Invest (1996) 1.39
Progressive loss of pancreatic function in chronic pancreatitis is delayed by main pancreatic duct decompression. A longitudinal prospective analysis of the modified puestow procedure. Ann Surg (1993) 1.38
Delivery of high concentrations of inspired oxygen via Tusk mask. Crit Care Med (1998) 1.38
Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res (1995) 1.36
The role of surgery in the Zollinger-Ellison syndrome. Ann Surg (1983) 1.36
Release of cholecystokinin in man: correlation of blood levels with gallbladder contraction. Ann Surg (1981) 1.34
A single amidotransferase forms asparaginyl-tRNA and glutaminyl-tRNA in Chlamydia trachomatis. J Biol Chem (2001) 1.32
Effect of metiamide, a histamine H2-receptor antagonist, on gastric response to histamine, pentagastrin, insulin, and peptone meal in man. Am J Dig Dis (1974) 1.32
Helicobacter pylori infection in gastric cancerogenesis. J Physiol Pharmacol (2009) 1.31
Effect of atropine on gastric acid response to graded doses of pentagastrin and histamine in duodenal ulcer patients before and after vagotomy. Am J Dig Dis (1968) 1.28
Release of pancreatic polypeptide in humans by infusion of cholecystokinin. Gastroenterology (1980) 1.28
Effect of medical and surgical vagotomy on gastric response to graded doses of pentagastrin and histamine. Gastroenterology (1968) 1.28
Clinical significance of gastrin receptors in human colon cancers. Cancer Res (1989) 1.27
Preoperative endoscopic retrograde cholangiopancreatography (ERCP) in patients with pancreatic pseudocyst associated with resolving acute and chronic pancreatitis. Ann Surg (1989) 1.26
Perianal abscess in Crohn's disease. Dis Colon Rectum (1997) 1.26
Distribution and release of epidermal growth factor in man. Gut (1989) 1.25
Gastrin stimulates growth of colon cancer. Surgery (1986) 1.24
Correlation of cholecystokinin receptors with gallbladder contractility in patients with gallstones. Ann Surg (1987) 1.24
Secretin, cholecystokinin and newer gastrointestinal hormones (first of two parts). N Engl J Med (1976) 1.24
Organ physiology of aging. Surg Clin North Am (1994) 1.24
Vagal cholinergic control of gastric alkaline secretion in normal subjects and duodenal ulcer patients. Gut (1987) 1.24
Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res (1994) 1.23
Helicobacter pylori-gastrin link in MALT lymphoma. Aliment Pharmacol Ther (2000) 1.23
Aorto-esophageal fistula: report of a case and review of literature. Gastroenterology (1967) 1.23
Effect of extragastric and truncal vagotomy on pancreatic secretion in the dog. Am J Physiol (1975) 1.23
Proglumide, a gastrin receptor antagonist, inhibits growth of colon cancer and enhances survival in mice. Ann Surg (1985) 1.22
Cephalic phase of gastric secretion in healthy subjects and duodenal ulcer patients: role of vagal innervation. Gut (1979) 1.22
Extraction of circulating endogenous gastrin by the small bowel. Gastroenterology (1973) 1.22
Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion. J Clin Invest (1976) 1.22
Gastric cytoprotection. Scand J Gastroenterol (1985) 1.21
An outbreak of suspected solanine poisoning in schoolboys: Examinations of criteria of solanine poisoning. Q J Med (1979) 1.21
Role of mucosal prostaglandins and DNA synthesis in gastric cytoprotection by luminal epidermal growth factor. Gut (1981) 1.21
Differential effects of gut hormones on pancreatic and intestinal growth during administration of an elemental diet. Ann Surg (1990) 1.20
Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. Gastroenterology (1998) 1.20
The human carcinoid cell line, BON. A model system for the study of carcinoid tumors. Ann N Y Acad Sci (1994) 1.20
Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic secretion. J Physiol (1976) 1.19
Renal inactivation of endogenous gastrin in dogs. Arch Surg (1973) 1.19
Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regul Pept (2004) 1.18
Comparison of amino acids bathing the oxyntic gland area in the stimulation of gastric secretion. Gastroenterology (1976) 1.18
Role of oxidative stress in the pathogenesis of caerulein-induced acute pancreatitis. Eur J Pharmacol (1999) 1.18
Effect of truncal vagotomy with pyloroplasty or with antrectomy on food-stimulated gastrin values in patients with duodenal ulcer. Surgery (1973) 1.17
The effect of secretin on gastric acid secretion and peptic ulcers induced by pentagastrin in cats with intact or resected duodenum. Am J Dig Dis (1968) 1.17
Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion. Pancreas (1994) 1.17
The conversion of laevulose and fatty acid into glucose. Biochem J (1941) 1.17
Gut clock: implication of circadian rhythms in the gastrointestinal tract. J Physiol Pharmacol (2011) 1.16
Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC-26) in BALB/c mice. Cancer Res (1986) 1.15
Renal uptake and excretion of gastrin in the dog. Surg Gynecol Obstet (1971) 1.15
Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans. J Physiol Pharmacol (1997) 1.15
Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions. Eur J Pharmacol (1999) 1.14
Rate and pattern of disappearance of exogenous gastrin in dogs. Am J Physiol (1972) 1.14
Effect of food on serum gastrin concentrations in duodenal ulcer and control patients. Surg Forum (1970) 1.14
Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. J Physiol Pharmacol (2007) 1.14
Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach. Eur J Immunol (2000) 1.13
Autoimmune hemolytic anemia with both cold and warm autoantibodies. JAMA (1985) 1.13
Identification of cholecystokinin-secreting cells. Lancet (1975) 1.13
Role of locally generated prostaglandins in adaptive gastric cytoprotection. Dig Dis Sci (1982) 1.12
Effect of metiamide, a histamine H2-receptor antagonist, on mucosal blood flow and serum gastrin level. Gastroenterology (1974) 1.12
Hormonal (gastrin, secretin, cholecystokinin) and secretory effects of bombesin and duodenal acidification in dogs. Surgery (1980) 1.12
The effect of cholinergic and adrenergic blockage on basal and pentagastrin-induced acid secretion. Scand J Gastroenterol (1969) 1.12
Surgical management of peptic ulcer disease today--indication, technique and outcome. Langenbecks Arch Surg (2000) 1.12
Somatostatin and analogues in the treatment of cancer. A review. Ann Surg (1991) 1.11
Infusion of pure cholecystokinin in humans. Correlation between plasma concentrations of cholecystokinin and gallbladder size. Gastroenterology (1982) 1.11
Effect of hepatic transit of gastrin, pentagastrin, and histamine measured by gastric secretion and by assay of hepatic vein blood. Ann Surg (1969) 1.11
Ghrelin attenuates the development of acute pancreatitis in rat. J Physiol Pharmacol (2003) 1.11
Endogenous nitric oxide in the control of esophageal motility in humans. J Physiol Pharmacol (1997) 1.10
Helicobacter pylori induces apoptosis in gastric mucosa through an upregulation of Bax expression in humans. Scand J Gastroenterol (1999) 1.10